Marcellusi A, Bini C, Rotundo MA, Cultrera R, Mennini FS. Cost-utility of dalbavancin in patients with non-severe ABSSSI in Italy. Grhta [Internet]. 2020 Nov. 6 [cited 2024 Apr. 23];7(1):92-100. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/2138